Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice

Circulation

Volumn 106, Issue 16, 2002, Pages 2125-2131

  Liao, Ronglih ^a   Jain, Mohit ^a   Cui, Lei ^a   D'Agostino, Jessica ^a   Aiello, Francesco ^a   Luptak, Ivan ^a   Ngoy, Soeun ^a   Mortensen, Richard M ^a   Tian, Rong ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Glucose; Heart failure; Metabolism

Indexed keywords

CREATINE PHOSPHATE; GLUCOSE; GLUCOSE TRANSPORTER 1; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE ACTIVATION; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; ISOLATED HEART; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; BIOLOGICAL TRANSPORT; CONSTRICTION; ECHOCARDIOGRAPHY; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MICE; MICE, TRANSGENIC; MONOSACCHARIDE TRANSPORT PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIUM; ORGAN CULTURE TECHNIQUES; PHOSPHOCREATINE; PRESSURE; SURVIVAL ANALYSIS; VENTRICULAR REMODELING;

EID: 0037109094     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000034049.61181.F3     Document Type: Article

References (30)

1. Katz AM. Heart Failure: Pathophysiology. Molecular Biology and Clinical Management, Philadelphia, Pa: Lippincott Williams & Wilkins; 2000.
2. Allard MF, Schonekess BO, Henning SL, et al. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol. 1994;267:H742-H750.
3. Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol. 1970;218:153-159.
4. Kagaya Y, Kanno Y, Takeyama D, et al. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats: a quantitative autoradiographic study. Circulation. 1990;81:1353-1361.
5. Nuutila P, Maki M, Laine H, et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest. 1995;96:1003-1009.
6. Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension. 1988;11:416-426.
7. Zhang J, Duncker DJ, Ya X, et al. Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake: a 31P NMR spectroscopic study. Circulation. 1995;92:1274-1283.
8. Paternostro G, Clarke K, Heath J, et al. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res. 1995;30:205-211.
9. Allard MF, Wambolt RB, Longnus SL, et al. Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am J Physiol Endocrinol Metab. 2000;279:E487-E493.
10. Tian R, Musi N, D'Agostino J, et al. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation. 2001;104:1664-1669.
11. Paternostro G, Pagano D, Gnecchi-Ruscone T, et al. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res. 1999;42:246-253.
12. Szwed H, Sadowski Z, Elikowski W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). Eur Heart J. 2001;22:2267-2274.
13. Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2000;86:580-588.
14. Chierchia SL. Dobutamine stress echocardiography and the effects of trimetazidine on left ventricular dysfunction in patients with coronary artery disease. Coron Artery Dis. 2001;12:S19-S21.
15. Jain M, Lim CC, Nagata K, et al. Targeted inactivation of Gα(i) does not alter cardiac function or β-adrenergic sensitivity. Am J Physiol Heart Circ Physiol. 2001;280:H569-H575.
16. Nagata K, Liao R, Eberli FR, et al. Early changes in excitationcontraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes. Cardiovasc Res. 1998;37:467-477.
17. Abel ED, Kaulbach HC, Tian R, et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest. 1999;104:1703-1714.
18. Carr RS, Neff JM. Quantitative semi-automated enzymatic assay for tissue glycogen. Comp Biochem Physiol [B]. 1984;77:447-449.
19. Ito K, Yan X, Tajima M, et al. Contractile reserve and intracellular calcium regulation in mouse myocytes from normal and hypertrophied failing hearts. Circ Res. 2000;87:588-595.
20. Ding B, Price RL, Goldsmith EC, et al. Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. Circulation. 2000;101:2854-2862.
21. Rockman HA, Wachhorst SP, Mao L, et al. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol. 1994;266:H2468-H2475.
22. Lopaschuk GD, Spafford MA, Marsh DR. Glycolysis is predominant source of myocardial ATP production immediately after birth. Am J Physiol. 1991;261:H1698-H1705.
23. Opie LH. Metabolism of the heart in health and disease, I. Am Heart J. 1968;76:685-698.
24. Barger PM, Kelly DP. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci. 1999;318:36-42.
25. Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol. 1994;26:1371-1375.
26. Goodwin GW, Ahmad F, Doenst T, et al. Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts. Am J Physiol. 1998;274:H1239-H1247.
27. Eichhorn EJ, Heesch CM, Barnett JH, et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1994;24:1310-1320.
28. Wallhaus TR, Taylor M, DeGrado TR, et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation. 2001;103:2441-2446.
29. Hermann HP, Pieske B, Schwarzmuller E, et al. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. Lancet. 1999;353:1321-1323.
30. Hasenfuss G, Maier LS, Hermann HP, et al. Influence of pyruvate on contractile performance and Ca(2+) cycling in isolated failing human myocardium. Circulation. 2002;105:194-199.